DSGN
Design Therapeutics, Inc.
+0.02 (+0.20%)12.53USD142K成交股數784M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | 0 | – | – | 0 | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 16.4M | 14.4M | 14.6M | 15.7M | 15.4M | 12.2M | 11.9M | 10.5M | 9.8M | 13.3M | 17.1M | 15.7M |
| 銷售管理費用 | 5.8M | 5.3M | 4.7M | 5.8M | 5.0M | 4.5M | 4.4M | 4.5M | 4.6M | 5.6M | 5.5M | 5.9M |
| 營業利益 | −22.2M+9% | −19.7M+18% | −19.3M+19% | −21.6M+43% | −20.4M+42% | −16.7M-11% | −16.2M-28% | −15.0M-31% | −14.4M | −18.8M | −22.6M | −21.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −20.2M+14% | −17.6M+29% | −17.0M+30% | −19.1M+62% | −17.7M+60% | −13.7M-14% | −13.0M-35% | −11.8M-39% | −11.1M | −15.8M | −19.9M | −19.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.32+3% | -0.29+21% | -0.30+30% | -0.34+62% | -0.31+55% | -0.24-14% | -0.23-36% | -0.21-40% | -0.20 | -0.28 | -0.36 | -0.35 |
| 稀釋股數 | 62.5M | 61.4M | 57.0M | 56.9M | 56.8M | 56.6M | 56.6M | 56.6M | 56.5M | 56.0M | 55.9M | 55.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 12.9M | 12.8M | 15.1M | 19.7M | 13.7M | 22.6M | 30.3M | 45.7M | 29.4M | 27.9M | 27.2M | 28.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 215M | 230M | 212M | 223M | 237M | 252M | 262M | 270M | 279M | 300M | 312M | 325M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 13.3M | 12.4M | 12.1M | 9.8M | 9.6M | 10.0M | 9.2M | 8.3M | 9.2M | 14.9M | 14.8M | 11.9M |
| 股東權益 | 202M | 218M | 200M | 213M | 228M | 242M | 252M | 261M | 270M | 285M | 297M | 313M |
| 負債比 | 6.2% | 5.4% | 5.7% | 4.4% | 4.0% | 4.0% | 3.5% | 3.1% | 3.3% | 5.0% | 4.8% | 3.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −16.4M | – | – | −16.8M+35% | – | – | – | −12.4M | – | – | −17.4M |
| 資本支出 | – | 0 | – | – | 72K | – | – | – | 195K | – | – | 87K |
| 自由現金流 | – | −16.4M | – | – | −16.9M+33% | – | – | – | −12.6M | – | – | −17.5M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0 | – | −69.8M | –% | -1.22 | −54.6M |
| FY2024 | 0 | – | −49.6M | –% | -0.88 | −43.4M |
| FY2023 | – | – | −66.9M | –% | -1.19 | −58.8M |
| FY2022 | – | – | −63.3M | –% | -1.14 | −52.2M |
| FY2021 | – | – | −35.5M | –% | -0.77 | −30.9M |
| FY2020 | 226K | – | −8.3M | -3,663.7% | -0.52 | −8.7M |